A meta-analysis of Hodgkin lymphoma reveals 19p13.3 TCF3 as a novel susceptibility locus

Nature Communications

Volumn 5, Issue , 2014, Pages

  Cozen, W ^a   Timofeeva, M N ^b,c   Li, D ^d   Diepstra, A ^e   Hazelett, D ^a   Delahaye Sourdeix, M ^b   Edlund, C K ^a   Franke, L ^e   Rostgaard, K ^f   Van Den Berg, D J ^a   Cortessis, V K ^a   Smedby, K E ^g   Glaser, S L ^h   Westra, H J ^e   Robison, L L ⁱ   Mack, T M ^a   Ghesquieres, H ^j   Hwang, A E ^a   Nieters, A ^k   De Sanjose, S ^l   Lightfoot, T ^m   Becker, N ⁿ   Maynadie, M ^o   Foretova, L ^p   Roman, E ^m   Benavente, Y ^l   Rand, K A ^a   Nathwani, B N ^q   Glimelius, B ^r   Staines, A ^s   Boffetta, P ^t   Link, B K ^u   Kiemeney, L ^v   Ansell, S M ^w   Bhatia, S ^q   Strong, L C ^x   Galan, P ^y   Vatten, L ^z   Habermann, T M ^w   Duell, E J ^l   Lake, A ^aa   Veenstra, R N ^e   Visser, L ^e   Liu, Y ^e   Urayama, K Y ^ab   Montgomery, D ^aa   Gaborieau, V ^b   Weiss, L M ^ac   Byrnes, G ^b   Lathrop, M ^ad   Cocco, P ^ae   Best, T ^af   Skol, A D ^af   Adami, H O ^g,ag   Melbye, M ^f   Cerhan, J R ^w   Gallagher, A ^aa   Taylor, G M ^ah   Slager, S L ^w   Brennan, P ^b   Coetzee, G A ^a   Conti, D V ^a   Onel, K ^af   Jarrett, R F ^aa   Hjalgrim, H ^f   Van Den Berg, A ^e   McKay, J D ^b   more..

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d CEDARS SINAI MEDICAL CENTER   (United States)

^e UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^f STATENS SERUM INSTITUT   (Denmark)

^g KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^h CANCER PREVENTION INSTITUTE OF CALIFORNIA   (United States)

ⁱ ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^j CENTRE LÉON BÉRARD   (France)

^k UNIVERSITY OF FREIBURG   (Germany)

^l CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^m UNIVERSITY OF YORK   (United Kingdom)

ⁿ GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^o UNIVERSITÉ DE BOURGOGNE   (France)

^p MASARYK MEMORIAL CANCER INSTITUTE   (Czech Republic)

^q CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^r UPPSALA UNIVERSITY   (Sweden)

^s DUBLIN CITY UNIVERSITY   (Ireland)

^t MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^u UNIVERSITY OF IOWA   (United States)

^v RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^w MAYO CLINIC   (United States)

^x UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^y INSERM   (France)

^z NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^aa MRC UNIVERSITY OF GLASGOW CENTRE FOR VIRUS RESEARCH   (United Kingdom)

^ab TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^ac Clarient Pathology Services Inc   (United States)

^ad Genome Centre Quebec   (Canada)

^ae UNIVERSITY OF CAGLIARI   (Italy)

^af UNIVERSITY OF CHICAGO   (United States)

^ag HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^ah UNIVERSITY OF MANCHESTER   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR 7 LIKE 1; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; TCF3 PROTEIN, HUMAN;

CELL ORGANELLE; DATA SET; DISEASE PREVALENCE; GENOME; HERITABILITY; META-ANALYSIS; RISK FACTOR;

ARTICLE; B LYMPHOCYTE; CELL LINEAGE; EPSTEIN BARR VIRUS; GENE LOCUS; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HLA SYSTEM; HODGKIN DISEASE; HUMAN; INTRON; META ANALYSIS; T LYMPHOCYTE; ADOLESCENT; ADULT; AGED; CASE CONTROL STUDY; CHROMOSOME 19; GENETIC PREDISPOSITION; GENETIC VARIATION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; MALE; MIDDLE AGED; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CASE-CONTROL STUDIES; CHROMOSOMES, HUMAN, PAIR 19; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; HODGKIN DISEASE; HUMANS; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84902440665     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms4856     Document Type: Article

References (57)

1. Mani, H. & Jaffe, E. Hodgkin lymphoma: an update on its biology with newer insights into classification. Clin. Lymph. Myeloma 9, 206-216 (2009).
2. Mueller, N. & Grufferman, S. in Cancer Epidemiology and Prevention (eds Schottenfeld, D. & Fraumeni, Jr J. F.) 872-898 (Oxford University Press, 2006).
3. Curado M. P. et al. (eds). Cancer Incidence in Five Continents Vol IX (WHO Press, 2008).
4. Cozen, W., Katz, J. & Mack, T. Hodgkin's disease varies by cell type in Los Angeles. Cancer Epidemiol. Biomarkers Preven. 1, 261-268 (1992).
5. Glaser, S. et al. Racial/ethnic variation in EBV-positive classical Hodgkin lymphoma in California populations. Int. J. Cancer 123, 1499-1507 (2008).
6. Hjalgrim, H. On the aetiology of Hodgkin lymphoma. Dan. Med. J. 59, B4485 (2012).
7. Mack, T. et al. Concordance for Hodgkin's disease in identical twins suggests genetic susceptibility to the young-adult form of the disease. New Eng. J. Med. 332, 413-418 (1995).
8. Grufferman, S., Cole, P., Smith, P. & Lukes, R. Hodgkin's disease in siblings. New Eng. J. Med. 296, 248-250 (1977). (Pubitemid 8030217)
9. Niens, M. et al. HLA-A*02 is associated with a reduced risk and HLA-A*01 with an increased risk of developing EBV Hodgkin lymphoma. Blood 110, 3310-3315 (2007). (Pubitemid 350106324)
10. Huang, X. et al. HLA associations in classical Hodgkin lymphoma: EBV status matters. PLoS ONE 7, e0039986 (2012).
11. Enciso-Mora, V. et al. A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p15.1 (REL), 8q24.21 and 10p14 (GATA3). Nat. Genet. 42, 1126-1230 (2010).
12. Urayama, K. et al. Genome-wide association study of classical Hodgkin lymphoma and Epstein-Barr virus status-defined subgroups. J. Nat. Cancer Inst. 104, 1-14 (2012).
13. Cozen, W. et al. A meta-analysis of nodular sclerosis Hodgkin lymphoma identifies risk loci at 6p21.32. Blood 119, 469-475 (2012).
14. Best, T. et al. Variants at 6q21 implicate PRDM1 in the etiology of therapy-induced second malignancies after Hodgkin lymphoma. Nat. Med. 17, 941-943 (2010).
15. Howie, B., Fuchsberger, C., Stephens, M., Marchini, J. & Abecasis, G. Fast and accurate genotype imputation in genome-wide association studies through pre-phasing. Nat. Genet. 44, 955-959 (2012).
16. Freedman, M. et al. Assessing the impact of population stratification on genetic association studies. Nat. Genet. 36, 388-393 (2004). (Pubitemid 38437262)
17. Frampton, M. et al. Variation at 3p24.1 and 6q23.3 influences the risk of Hodgkin lymphoma. Nat. Commun. 4, e2549 (2013).
18. Coetzee, S., Rhie, S., Berman, B., Coetzee, G. & Noushmehr, H. FunciSNP: an R/bioconductor tool integrating functional non-coding data sets with genetic association studies to identify candidate regulatory SNPs. Nucleic Acids Res. 40, e139 (2012).
19. - 1000 Genomes Project Consortium et al. An integrated map of genetic variation from 1, 092 human genomes. Nature 491, 56-65 (2012).
20. Khatun, J. et al. Whole human genome proteogenomic mapping for ENCODE cell line data: identifying protein-coding regions. BMC Genomics 14, 141 (2013).
21. Yang, T. et al. Genevar: a database and Java application for the analysis and visualization of SNP-gene associations in eQTL studies. Bioinformatics. 26, 2474-2476 (2010).
22. Schmitz, R. et al. Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics. Nature 490, 116-120 (2012).
23. Fairfax, B. et al. Genetics of gene expression in primary immune cells identifies cell type-specific master regulators and roles of HLA alleles. Nat. Genet. 445, 502-510 (2012).
24. Kwon, K. et al. Instructive role of the transcription factor E2A in early B lymphopoiesis and germinal center B cell development. Immunity 28, 751-762 (2008).
25. Lazorchak, A., Wojciechowski, J., Dai, M. & Zhuang, Y. E2A promotes the survival of precursor and mature B lymphocytes. J. Immunol. 177, 2495-2504 (2006). (Pubitemid 44201009)
26. Renné, C. et al. Aberrant expression of ID2, a suppressor of B-cell-specific gene expression, in Hodgkin's lymphoma. Am. J. Pathol. 169, 655-664 (2006). (Pubitemid 44156321)
27. Mathas, S. et al. Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma. Nat. Immunol. 7, 207-215 (2006). (Pubitemid 43135887)
28. Van der Put, E., Frasca, D., King, A., Blomberg, B. & Riley, R. Decreased E47 in senescent B cell precursors is stage specific and regulated posttranslationally by protein turnover. J. Immunol. 173, 818-827 (2004). (Pubitemid 38924256)
29. Besson, H. et al. Tobacco smoking, alcohol drinking and Hodgkin's lymphoma: a European multi-centre case-control study (EPILYMPH). Br. J. Cancer 95, 378-384 (2006). (Pubitemid 44187602)
30. Jarrett, R. et al. The Scotland and Newcastle epidemiological study of Hodgkin's disease: impact of histopathological review and EBV status on incidence estimates. J. Clin. Pathol. 56, 811-816 (2003). (Pubitemid 37386566)
31. Smedby, K. et al. Ultraviolet radiation exposure and risk of malignant lymphomas. J. Natl Cancer Inst. 97, 199-209 (2005). (Pubitemid 40277370)
32. Hjalgrim, H. et al. HLA-A alleles and infectious mononucleosis suggest a critical role for cytotoxic T-cell response in EBV-related Hodgkin lymphoma. Proc. Natl Acad. Sci. USA 107, 6400-6405 (2010).
33. Diepstra, A. et al. Association with HLA class I in Epstein-Barr-virus- positive and with HLA class III in Epstein-Barr-virus-negative Hodgkin's lymphoma. Lancet 365, 2216-2224 (2005). (Pubitemid 40853915)
34. Lagiou, P. et al. Alcohol-related cancers and genetic susceptibility in Europe: the ARCAGE project: study samples and data collection. Eur. J. Cancer Prev. 18, 76-84 (2009).
35. Hashibe, M. et al. Multiple ADH genes are associated with upper aerodigestive cancers. Nat. Genet. 40, 707-709 (2008). (Pubitemid 351748869)
36. Amundadottir, L. et al. Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat. Genet. 41, 986-990 (2009).
37. Wetzels, J., Kiemeney, L., Swinkels, D., Willems, H. & den Heijer, M. Age-and gender-specific reference values of estimated GFR in Caucasians: the Nijmegen Biomedical Study. Kidney Int. 72, 632-637 (2007). (Pubitemid 47312796)
38. Wellcome Trust Case Control Consortium. Genome-wide association study of 14, 000 cases of seven common diseases and 3, 000 shared controls. Nature 447, 661-678 (2007).
39. Cozen, W. et al. The USC adult twin cohorts: international twin study and california twin program. Twin Res. Hum. Genet. 16, 366-370 (2013).
40. Weiss, L., Chen, Y., Liu, X. & Shibata, D. Epstein-Barr virus and Hodgkin's disease. A correlative in situ hybridization and polymerase chain reaction study. Am. J. Pathol. 139, 1259-1265 (1991).
41. Mailman, M. et al. The NCBI dbGaP database of genotypes and phenotypes. Nat. Genet. 39, 1181-1186 (2007). (Pubitemid 47482671)
42. Hunter, D. et al. A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat. Genet. 39, 870-874 (2007). (Pubitemid 47014500)
43. Robison, L. et al. The Childhood Cancer Survivor Study: a National Cancer Institute-supported resource for outcome and intervention research. J. Clin. Oncol. 27, 2308-2318 (2009).
44. GAIN Collaborative Research Group et al. New models of collaboration in genome-wide association studies: the Genetic Association Information Network. Nat. Genet. 39, 1045-1051 (2007).
45. Howie, B., Donnelly, P. & Marchini, J. A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet. 5, e1000529 (2009).
46. Li, Y., Willer, C., Ding, J., Scheet, P. & Abecasis, G. MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes. Genet. Epidemiol. 34, 816-834 (2010).
47. Casasnovas, R. et al. Plasma cytokine and soluble receptor signature predicts outcome of patients with classical Hodgkin's lymphoma: a study from the Groupe d'Etude des Lymphomes de l'Adulte. J. Clin. Oncol. 25, 1732-1740 (2007). (Pubitemid 46797954)
48. Willett, E. V., O'Connor, S., Smith, A. G. & Roman, E. Does smoking or alcohol modify the risk of Epstein-Barr virus-positive or negative Hodgkin lymphoma? Epidemiology. 18, 130-136 (2007). (Pubitemid 46005917)
49. Cerhan, J. et al. Design and validity of a clinic-based case-control study on the molecular epidemiology of lymphoma. Int. J. Mol. Epidemiol. Genet. 2, 95-113 (2011).
50. Purcell, S. et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 81, 559-575 (2007). (Pubitemid 47330214)
51. Pruim, R. et al. LocusZoom: regional visualization of genome-wide association scan results. Bioinformatics 26, 2336-2337 (2010).
52. Johnson, A. et al. SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap. Bioinformatics 24, 2938-2939 (2008).
53. Price, A. et al. Principal components analysis corrects for stratification in genome-wide association studies. Nat. Genet. 38, 904-909 (2006). (Pubitemid 44141658)
54. Stram, D. O. D., Analysis, and Interpretation of Genome-Wide Association Scans (eds Gail, M., Krickenberg, K., Samet, J., Tsiatis, A. & Wong, W.) (Springer, 2014).
55. Kent, W. et al. The human genome browser at UCSC. Genome Res. 12, 996-1006 (2002). (Pubitemid 34662293)
56. Wang, J. et al. Sequence features and chromatin structure around the genomic regions bound by 119 human transcription factors. Genome Res. 22, 1798-1812 (2012).
57. Poppema, S. et al. Immunologic, enzyme histochemical and chromosomal analysis of a cell line derived from Hodgkin's disease. Evidence for a B-cell origin of Sternberg-Reed cells. Cancer 55, 683-690 (1985). (Pubitemid 15173503)